U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 20 of 23

Tests names and labsConditionsGenes, analytes, and microbesMethods

SERPINA1 sequencing

Genetics Laboratory, Trillium Health Partners Trillium Health Partners, Credit Valley Hospital Site
Canada
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Emphysema-cirrhosis, due to AAT deficiency, 613490, Autosomal recessive (Alpha-1-antitrypsin deficiency) (Prenatal) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Emphysema-cirrhosis, due to AAT deficiency, 613490, Autosomal recessive (Alpha-1-antitrypsin deficiency) (SERPINA1 gene) (Sequence Analysis-All Coding Exons) (Prenatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Emphysema-cirrhosis, due to AAT deficiency, 613490, Autosomal recessive (Alpha-1-antitrypsin deficiency) (SERPINA1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Emphysema-cirrhosis, due to AAT deficiency, 613490, Autosomal recessive (Alpha-1-antitrypsin deficiency) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Pulmonary disease, chronic obstructive, susceptibility to, 606963 (HMOX1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

COPD, rate of decline of lung function in, 606963 (MMP1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Alpha-1 Antitrypsin Deficiency (SERPINA1 Single Gene Test)

Fulgent Genetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Primary Immunodeficiency NGS Panel

Fulgent Genetics
United States
1048472
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Beacon Expanded Female Carrier Screening Plus Panel

Fulgent Genetics
United States
716335
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Beacon Expanded Male Carrier Screening Plus Panel

Fulgent Genetics
United States
661306
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

HIRA Single Gene

Fulgent Genetics
United States
851
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

ARVCF Single Gene

Fulgent Genetics
United States
851
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

NFKB1 Single Gene

Fulgent Genetics
United States
251
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

SERPINA1 Single Gene

Fulgent Genetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

MMP1 Single Gene

Fulgent Genetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

HMOX1 Single Gene

Fulgent Genetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Cholestasis NGS Panel

Fulgent Genetics
United States
12166
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clinical Exome

Fulgent Genetics
United States
51294672
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Lung Disorders NGS Panel

Fulgent Genetics
United States
7651
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 23

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.